Outsourced Pharma Capabilities Update August 2026: Oral Solid Dose Formulation

Oral solid dose programs can run into costly scale-up challenges when early formulation and process decisions aren’t built for long-term manufacturability.

Join leading CDMO experts on August 18 at 1:00 PM ET to explore how excipient selection, granulation strategy, particle engineering, and process design can impact tech transfer, validation, and commercial manufacturing.

Register now to gain practical insights for evaluating CDMO capabilities, identifying scale-up risks earlier, and making more informed partner selection decisions.